Context Therapeutics Inc. Cash Flow Statement

Cash Flow Statement Dec2020 Dec2021 Dec2022 Dec2024
Operating Activities
Net Income -3.23M-10.59M
Share-based Compensation 0.22M0.51M0.98M0.84M
Gains from Investment Securities 0.37M0.13M0.26M
Cash from Operations -1.03M-8.80M-13.55M-14.56M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges 0.66M0.05M
Depreciation & Amortization (CF) 0.01M0.01M
Change in Working Capital
Change in Account Payables 0.56M-0.87M-0.79M-0.95M
Change in Accured Expenses 0.76M0.25M1.35M-0.62M
Other Working Capital Changes -0.00M1.61M0.74M1.87M
Investing Activities
Capital Expenditures 0.04M0.01M
Cash from Investing Activities -0.25M-0.54M-14.76M
Financing Activities
Other financing activities 0.10M
Cash from Financing Activities 1.15M58.39M-0.10M109.29M
Additional items
Change in Cash 0.11M49.34M-14.19M79.98M
Beginning Cash Balance -0.11M-49.34M14.19M-79.98M
Free Cash Flow -1.03M-8.80M-13.59M-14.56M
Net Cash Flow 0.11M49.34M-14.19M79.98M